Loomis, Sayles & Company’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $30.8M | Sell |
|
|||||
|
2024
Q1 | $69.2M | Buy |
|
|||||
|
2023
Q4 | $65.9M | Sell |
|
|||||
|
2023
Q3 | $55.7M | Sell |
|
|||||
|
2023
Q2 | $67.9M | Sell |
|
|||||
|
2023
Q1 | $73.9M | Buy |
|
|||||
|
2022
Q4 | $53.8M | Sell |
|
|||||
|
2022
Q3 | $94.5M | Buy |
|
|||||
|
2022
Q2 | $77.2M | Sell |
|
|||||
|
2022
Q1 | $81.6M | Buy |
|
|||||
|
2021
Q4 | $54.9M | Buy |
|
|||||
|
2021
Q3 | $49.2M | Buy |
|
|||||
|
2021
Q2 | $18.4M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $15.3M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $5.93M | Sell |
|
|||||
|
2016
Q3 | $14.1M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $786K | Buy |
|
|||||
|
2015
Q2 | $625K | Buy |
|